Robert Allen
Hoofd Techniek/Wetenschap/O&O bij INVIVYD, INC.
Vermogen: - $ op 31-05-2024
Profiel
Robert D.
Allen is currently the Chief Scientific Officer at Invivyd, Inc. He previously worked as the Scientific Director at Oregon Translational Research & Development Institute and as the Senior Vice President-Research & Development at Sorrento Therapeutics, Inc. From 2020 to 2023, he served as the Chief Scientific Officer at SmartPharm Therapeutics, Inc. Dr. Allen holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Georgia Institute of Technology, and an undergraduate degree from Rhodes College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 22-03-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Robert Allen
| Bedrijven | Functie | Begin |
|---|---|---|
| INVIVYD, INC. | Hoofd Techniek/Wetenschap/O&O | 12-04-2023 |
Eerdere bekende functies van Robert Allen
| Bedrijven | Functie | Einde |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| Oregon Translational Research & Development Institute | Hoofd Techniek/Wetenschap/O&O | - |
| SORRENTO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Robert Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
